Valproic acid promotes human hair growth in in vitro culture model

Journal of Dermatological Science

Volumn 72, Issue 1, 2013, Pages 16-24

  Jo, Seong Jin ^a,b,c   Choi, Soon Jin ^a   Yoon, Sun Young ^a   Lee, Ji Yeon ^a   Park, Won Seok ^d   Park, Phil June ^d   Kim, Kyu Han ^a,b,c   Eun, Hee Chul ^a,b,c   Kwon, Ohsang ^a,b,c  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d AmorePacific Corporation   (South Korea)

Author keywords

catenin; Dermal papilla; GSK 3 ; Hair; Valproic acid

Indexed keywords

BETA CATENIN; BONE MORPHOGENETIC PROTEIN; FIBROBLAST GROWTH FACTOR 10; GLYCOGEN SYNTHASE KINASE 3; SOMATOMEDIN C; TRICHOSTATIN A; VALPROIC ACID;

ADULT; ALOPECIA; ANIMAL EXPERIMENT; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; HAIR FOLLICLE; HAIR GROWTH; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SKIN CELL;

DERMAL PAPILLA; GSK-3 Β; HAIR; VALPROIC ACID; Β-CATENIN;

ALKALINE PHOSPHATASE; ANIMALS; AXIN PROTEIN; BETA CATENIN; CELL SURVIVAL; FEMALE; GENE EXPRESSION; GLYCOGEN SYNTHASE KINASE 3; HAIR; HAIR FOLLICLE; HISTONE DEACETYLASE INHIBITORS; HUMANS; HYDROXAMIC ACIDS; MICE; MICE, INBRED C57BL; SIGNAL TRANSDUCTION; TISSUE CULTURE TECHNIQUES; VALPROIC ACID;

EID: 84883817133     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2013.05.007     Document Type: Article

References (66)

1. Paus R., Cotsarelis G. The biology of hair follicles. N Engl J Med 1999, 341:491-497.
2. Cotsarelis G. Epithelial stem cells: a folliculocentric view. J Invest Dermatol 2006, 126:1459-1468.
3. Millar S.E. Molecular mechanisms regulating hair follicle development. J Invest Dermatol 2002, 118:216-225.
4. Stenn K.S., Paus R. Controls of hair follicle cycling. Physiol Rev 2001, 81:449-494.
5. Yang C.C., Cotsarelis G. Review of hair follicle dermal cells. J Dermatol Sci 2010, 57:2-11.
6. Ridanpaa M., Fodde R., Kielman M. Dynamic expression and nuclear accumulation of beta-catenin during the development of hair follicle-derived structures. Mech Dev 2001, 109:173-181.
7. Maretto S., Cordenonsi M., Dupont S., Braghetta P., Broccoli V., Hassan A.B., et al. Mapping Wnt/β-catenin signaling during mouse development and in colorectal tumors. Proc Natl Acad Sci U S A 2003, 100:3299-3304.
8. Kishimoto J., Burgeson R.E., Morgan B.A. Wnt signaling maintains the hair-inducing activity of the dermal papilla. Genes Dev 2000, 14:1181-1185.
9. Shimizu H., Morgan B.A. Wnt signaling through the β-catenin pathway is sufficient to maintain, but not restore, anagen-phase characteristics of dermal papilla cells. J Invest Dermatol 2004, 122:239-245.
10. Enshell-Seijffers D., Lindon C., Kashiwagi M., Morgan B.A. β-Catenin activity in the dermal papilla regulates morphogenesis and regeneration of hair. Dev Cell 2010, 18:633-642.
11. Wiltse J. Mode of action: inhibition of histone deacetylase, altering WNT-dependent gene expression, and regulation of beta-catenin - developmental effects of valproic acid. Crit Rev Toxicol 2005, 35:727-738.
12. Perucca E. Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience. CNS Drugs 2002, 16:695-714.
13. Werstuck G.H., Kim A.J., Brenstrum T., Ohnmacht S.A., Panna E., Capretta A. Examining the correlations between GSK-3 inhibitory properties and anti-convulsant efficacy of valproate and valproate-related compounds. Bioorg Med Chem Lett 2004, 14:5465-5467.
14. Rosenberg G. The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees?. Cell Mol Life Sci 2007, 64:2090-2103.
15. Chen G., Huang L.D., Jiang Y.M., Manji H.K. The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. J Neurochem 1999, 72:1327-1330.
16. Grimes C.A., Jope R.S. CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J Neurochem 2001, 78:1219-1232.
17. Kim A.J., Shi Y., Austin R.C., Werstuck G.H. Valproate protects cells from ER stress-induced lipid accumulation and apoptosis by inhibiting glycogen synthase kinase-3. J Cell Sci 2005, 118:89-100.
18. Phiel C.J., Zhang F., Huang E.Y., Guenther M.G., Lazar M.A., Klein P.S. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 2001, 276:36734-36741.
19. Jonathan Ryves W., Dalton E.C., Harwood A.J., Williams R.S.B. GSK-3 activity in neocortical cells is inhibited by lithium but not carbamazepine or valproic acid. Bipolar Disord 2005, 7:260-265.
20. Messenger A. The culture of dermal papilla cells from human hair follicles. Br J Dermatol 1984, 110:685-689.
21. Randall V.A., Thornton M.J., Redfern C.P.F. Dermal papilla cells from human hair follicles express mRNA for retinoic acid receptors in culture. Ann N Y Acad Sci 1991, 642:457-458.
22. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983, 65:55-63.
23. Philpott M.P., Green M.R., Kealey T. Human hair growth in vitro. J Cell Sci 1990, 97:463-471.
24. Yoon S.Y., Kim K.T., Jo S.J., Cho A.R., Jeon S.I., Choi H.D., et al. Induction of hair growth by insulin-like growth factor-1 in 1763MHz radiofrequency-irradiated hair follicle cells. PLoS ONE 2011, 6:e28474.
25. Paus R., Stenn K., Link R. The induction of anagen hair growth in telogen mouse skinby cyclosporine A administration. Lab Invest 1989, 60:365-369.
26. Muller-Rover S., Handjiski B., van der Veen C., Eichmuller S., Foitzik K., McKay I.A., et al. A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol 2001, 117:3-15.
27. Arck P.C., Handjiski B., Peters E.M.J., Hagen E., Klapp B.F., Paus R. Topical minoxidil counteracts stress induced hair growth inhibition in mice. Exp Dermatol 2003, 12:580-590.
28. Maurer M., Peters E.M.J., Botchkarev V.A., Paus R. Intact hair follicle innervation is not essential for anagen induction and development. Arch Dermatol Res 1998, 290:574-578.
29. Kwon O.S., Pyo H.K., Oh Y.J., Han J.H., Lee S.R., Chung J.H., et al. Promotive effect of minoxidil combined with all-trans retinoic acid (tretinoin) on human hair growth in vitro. J Korean Med Sci 2007, 22:283-289.
30. Boukamp P., Petrussevska R.T., Breitkreutz D., Hornung J., Markham A., Fusenig N.E. Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 1988, 106:761-771.
31. Sutherland C., Leighton I.A., Cohen P. Inactivation of glycogen synthase kinase-3 beta by phosphorylation: new kinase connections in insulin and growth-factor signalling. Biochem J 1993, 296:15-19.
32. Woodgett J.R. Judging a protein by more than its name: GSK-3. Sci STKE 2001, 2001:re12.
33. Yamauchi K., Kurosaka A. Inhibition of glycogen synthase kinase-3 enhances the expression of alkaline phosphatase and insulin-like growth factor-1 in human primary dermal papilla cell culture and maintains mouse hair bulbs in organ culture. Arch Dermatol Res 2009, 301:357-365.
34. Soma T., Fujiwara S., Shirakata Y., Hashimoto K., Kishimoto J. Hair-inducing ability of human dermal papilla cells cultured under Wnt/β-catenin signalling activation. Exp Dermatol 2012, 21:307-309.
35. Rendl M., Lewis L., Fuchs E. Molecular dissection of mesenchymal-epithelial interactions in the hair follicle. PLoS Biol 2005, 3:e331.
36. Jho E., Zhang T., Domon C., Joo C.K., Freund J.N., Costantini F. Wnt/beta-catenin/Tcf signaling induces the transcription of axin2, a negative regulator of the signaling pathway. Mol Cell Biol 2002, 22:1172.
37. Ohyama M., Veraitch O. Strategies to enhance epithelial-mesenchymal interactions for human hair follicle bioengineering. J Dermatol Sci 2013, 70:78-87.
38. Driskell R.R., Juneja V.R., Connelly J.T., Kretzschmar K., Tan D.W.-M., Watt F.M. Clonal growth of dermal papilla cells in hydrogels reveals intrinsic differences between Sox2-positive and-negative cells in vitro and in vivo. J Invest Dermatol 2012, 132:1084-1093.
39. Barreca A., de Luca M., Monte P.D., Bondanza S., Damonte G., Cariola G., et al. In vitro paracrine regulation of human keratinocyte growth by fibroblast-derived insulin-like growth factors. J Cell Physiol 1992, 151:262-268.
40. Greco V., Chen T., Rendl M., Schober M., Pasolli H.A., Stokes N., et al. A two-step mechanism for stem cell activation during hair regeneration. Cell Stem Cell 2009, 4:155-169.
41. Watanabe K., Dai X. Winning WNT: race to Wnt signaling inhibitors. Proc Natl Acad Sci U S A 2011, 108:5929-5930.
42. Gurvich N., Tsygankova O.M., Meinkoth J.L., Klein P.S. Histone deacetylase is a target of valproic acid-mediated cellular differentiation. Cancer Res 2004, 64:1079-1086.
43. Strahl B.D., Allis C.D. The language of covalent histone modifications. Nature 2000, 403:41-45.
44. Paus R., Heinzelmann T., Schultz K.D., Furkert J., Fechner K., Czarnetzki B.M. Hair growth induction by substance P. Lab Invest 1994, 71:134-140.
45. Paus R., Muller-Rover S., van der Veen C., Maurer M., Eichmuller S., Ling G., et al. A comprehensive guide for the recognition and classification of distinct stages of hair follicle morphogenesis. J Invest Dermatol 1999, 113:523-532.
46. DasGupta R., Fuchs E. Multiple roles for activated LEF/TCF transcription complexes during hair follicle development and differentiation. Development 1999, 126:4557-4568.
47. Huelsken J., Vogel R., Erdmann B., Cotsarelis G., Birchmeier W. Beta-catenin controls hair follicle morphogenesis and stem cell differentiation in the skin. Cell 2001, 105:533-545.
48. Zhang Y., Andl T., Yang S.H., Teta M., Liu F., Seykora J.T., et al. Activation of β-catenin signaling programs embryonic epidermis to hair follicle fate. Development 2008, 135:2161-2172.
49. Ito M., Yang Z., Andl T., Cui C., Kim N., Millar S.E., et al. Wnt-dependent de novo hair follicle regeneration in adult mouse skin after wounding. Nature 2007, 447:316-320.
50. Kwack M.H., Sung Y.K., Chung E.J., Im S.U., Ahn J.S., Kim M.K., et al. Dihydrotestosterone-inducible dickkopf 1 from balding dermal papilla cells causes apoptosis in follicular keratinocytes. J Invest Dermatol 2008, 128:262-269.
51. Kitagawa T., Matsuda K.I., Inui S., Takenaka H., Katoh N., Itami S., et al. Keratinocyte growth inhibition through the modification of Wnt signaling by androgen in balding dermal papilla cells. J Clin Endocrinol Metab 2009, 94:1288-1294.
52. Leirós G., Attorresi A., Balañá M. Hair follicle stem cell differentiation is inhibited through a cross talk between Wnt/β-catenin and androgen signalling in dermal papilla cells from patients with androgenetic alopecia. Br J Dermatol 2012, 166:1035-1042.
53. Johannessen C.U. Mechanisms of action of valproate: a commentatory. Neurochem Int 2000, 37:103-110.
54. Blaheta R.A., Cinatl J. Anti-tumor mechanisms of valproate: a novel role for an old drug. Med Res Rev 2002, 22:492-511.
55. Lee S.H., Yoon J., Shin S.H., Zahoor M., Kim H.J., Park P.J., et al. Valproic acid induces hair regeneration in murine model and activates alkaline phosphatase activity in human dermal papilla cells. PLoS ONE 2012, 7:e34152.
56. Park P.J., Moon B.S., Lee S.H., Kim S.N., Kim A.R., Kim H.J., et al. Hair growth-promoting effect of Aconiti Ciliare Tuber extract mediated by the activation of Wnt/β-catenin signaling. Life Sci 2012, 91:935-943.
57. Stoll C., Audeoud F., Gaugler C., Bernardin A., Messer J. Multiple congenital malformations including generalized hypertrichosis with gum hypertrophy in a child exposed to valproic acid in utero. Genet Couns 2003, 14:289-298.
58. Mercke Y., Sheng H., Khan T., Lippmann S. Hair loss in psychopharmacology. Ann Clin Psychiatry 2000, 12:35-42.
59. Davis R., Peters D., McTavish D. Valproic acid. A reappraisal of its pharmacological properties and clinical efficacy in epilepsy. Drugs 1994, 47:332-372.
60. McKinney P., Finkenbine R., DeVane C. Alopecia and mood stabilizer therapy. Ann Clin Psychiatry 1996, 8:183-185.
61. Schulpis K.H., Karikas G.A., Tjamouranis J., Regoutas S., Tsakiris S. Low serum biotinidase activity in children with valproic acid monotherapy. Epilepsia 2001, 42:1359-1362.
62. Arslan M., Vurucu S., Balamtekin N., Unay B., Akin R., Kurt I., et al. The effects of biotin supplementation on serum and liver tissue biotinidase enzyme activity and alopecia in rats which were administrated to valproic acid. Brain Dev 2009, 31:405-410.
63. Castro-Gago M., Gomez-Lado C., Eiris-Pu al J., Diaz-Mayo I., Castineiras-Ramos D. Serum biotinidase activity in children treated with valproic acid and carbamazepine. J Child Neurol 2010, 25:32-35.
64. Yilmaz Y., Tasdemir H.A., Paksu M.S. The influence of valproic acid treatment on hair and serum zinc levels and serum biotinidase activity. Eur J Paediatr Neurol 2009, 13:439-443.
65. Grier R., Heard G., Watkins P., Wolf B. Low biotinidase activities in the sera of patients with impaired liver function: evidence that the liver is the source of serum biotinidase. Clin Chim Acta 1990, 186:397-400.
66. Van Lint C., Emiliani S., Verdin E. The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expression 1996, 5:245.